There is a wide consensus among scholars of the pharmaceutical sector that the American pharmaceutical sector has been much more dynamic and successful than the European one from the mid-1990s onward. The aim of this paper is to reconsider the statistical limelights commonly adopted to justify...

With aim of providing useful policy suggestion, it seems advisable to keep under consideration the assumptions underlying the Health Industry Model-HIM (Di Tommaso, Schweitzer 2000). This paper aims at providing useful information to gain an insight into a few typical behaviors of businesses in...

The paper focuses on the recent evolution in performance of healthcare production in Italy. It regards the technical efficiency and equity in the use of public funds in public primary healthcare actions, concerning the funding profile in the new scenario of fiscal federalism. The analysis is...

In the pharmaceutical industry, large-scale research and innovation have been broadly recognized as the major drivers of performance. While this paradigm is still valid, owing to the need to increase firms dimension in order to cope with the high risks related with innovation processes, it would...